{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:48:37Z","timestamp":1791672517790,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of Shandong Province","award":["No. ZR2023MH208"],"award-info":[{"award-number":["No. ZR2023MH208"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07154-2","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:46:48Z","timestamp":1782560808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allogeneic hematopoietic stem cell transplantation for a pediatric case of myelodysplastic syndrome with germline DDX41 mutation"],"prefix":"10.1007","volume":"105","author":[{"given":"Tiantian","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"7154_CR1","doi-asserted-by":"crossref","unstructured":"Quesada AE, Routbort MJ, DiNardo CD et al (2019) DDX41 variants in myeloid neoplasms are associated with male gender, TP53 variants and high-risk disease. Am J Hematol 94(7):757\u2013766. https:\/\/doi.10.1002\/ajh.25486","DOI":"10.1002\/ajh.25486"},{"issue":"17","key":"7154_CR2","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1182\/blood.2019000909","volume":"134","author":"M S\u00e9bert","year":"2019","unstructured":"S\u00e9bert M, Passet M, Raimbault A et al (2019) Germline DDX41 mutations define a significant entity within adult MDS\/AML patients. Blood 134(17):1441\u20131444. https:\/\/doi.org\/10.1182\/blood.2019000909","journal-title":"Blood"},{"key":"7154_CR3","doi-asserted-by":"crossref","unstructured":"Alkhateeb HB, Nanaa A, Viswanatha D et al (2022) Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms. Blood Adv 25;6(2):528\u2013532. https:\/\/doi.10.1182\/bloodadvances.2021005738","DOI":"10.1182\/bloodadvances.2021005738"},{"issue":"13","key":"7154_CR4","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood-2017-09-765214","volume":"131","author":"F Locatelli","year":"2018","unstructured":"Locatelli F, Strahm B (2018) How I treat myelodysplastic syndromes of childhood. Blood 131(13):1406\u20131414. https:\/\/doi.org\/10.1182\/blood-2017-09-765214","journal-title":"Blood"},{"key":"7154_CR5","doi-asserted-by":"crossref","unstructured":"Wan Z, Han B (2021) Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data. Ther Adv Hematol 12:1\u201312. https:\/\/doi.10.1177\/20406207211032433","DOI":"10.1177\/20406207211032433"},{"issue":"25","key":"7154_CR6","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","volume":"125","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu QF, Xu LP et al (2015) Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood 125(25):3956\u20133962. https:\/\/doi.org\/10.1182\/blood-2015-02-627786","journal-title":"Blood"},{"key":"7154_CR7","doi-asserted-by":"crossref","unstructured":"Bashey ZA, Zhang X, Brown S et al (2018) Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older. Bone Marrow Transplant 53(6):756\u2013763. https:\/\/doi.10.1038\/s41409-018-0126-4","DOI":"10.1038\/s41409-018-0126-4"},{"issue":"7","key":"7154_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood.2021015328","volume":"140","author":"N Duployez","year":"2022","unstructured":"Duployez N, Largeaud L, Duchmann M et al (2022) Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. Blood 140(7):756\u2013768. https:\/\/doi.org\/10.1182\/blood.2021015328","journal-title":"Blood"},{"key":"7154_CR9","doi-asserted-by":"crossref","unstructured":"Kambara Y, Sadato D, Toya T et al (2024) Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation. Leukemia 38(3):667\u2013670. https:\/\/doi.10.1038\/s41375-024-02152-7","DOI":"10.1038\/s41375-024-02152-7"},{"key":"7154_CR10","doi-asserted-by":"crossref","unstructured":"Saygin C, Roloff G, Hahn CN et al (2023) Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies. Blood Adv 7(4):549\u2013554. https:\/\/doi.10.1182\/bloodadvances.2022008172","DOI":"10.1182\/bloodadvances.2022008172"},{"key":"7154_CR11","doi-asserted-by":"crossref","unstructured":"Bataller A, Loghavi S, Gerstein Y et al (2023) Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants. Am J Hematol 98(11):1780\u20131790. https:\/\/doi.10.1002\/ajh.27070","DOI":"10.1002\/ajh.27070"},{"issue":"5","key":"7154_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1182\/blood.2022018221","volume":"141","author":"H Makishima","year":"2023","unstructured":"Makishima H, Saiki R, Nannya Y et al (2023) Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood 141(5):534\u2013549. https:\/\/doi.org\/10.1182\/blood.2022018221","journal-title":"Blood"},{"issue":"1","key":"7154_CR13","doi-asserted-by":"publisher","first-page":"2338509","DOI":"10.1080\/16078454.2024.2338509","volume":"29","author":"X Wang","year":"2024","unstructured":"Wang X, Xiao Z, Qin T et al (2024) Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutations. Hematology 29(1):2338509. https:\/\/doi.org\/10.1080\/16078454.2024.2338509","journal-title":"Hematology"},{"issue":"2","key":"7154_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/leu.2016.310","volume":"31","author":"G Berger","year":"2017","unstructured":"Berger G, van den Berg E, Sikkema-Raddatz B et al (2017) Reemergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation. Leukemia 31(2):520\u2013522. https:\/\/doi.org\/10.1038\/leu.2016.310","journal-title":"Leukemia"},{"issue":"2","key":"7154_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1200\/JCO.21.02286","volume":"40","author":"CJ Gibson","year":"2022","unstructured":"Gibson CJ, Kim HT, Zhao L et al (2022) Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation. J Clin Oncol 40(2):189\u2013201. https:\/\/doi.org\/10.1200\/JCO.21.02286","journal-title":"J Clin Oncol"},{"key":"7154_CR16","doi-asserted-by":"crossref","unstructured":"Gurnari C, Robin M, Godley LA et al (2023) Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT. Lancet Haematol 10(12):e994-e1005. https:\/\/doi.10.1016\/S2352-3026(23)00265-X","DOI":"10.1016\/S2352-3026(23)00265-X"},{"issue":"14","key":"7154_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.14715\/cmb\/2023.69.14.11","volume":"69","author":"L Li","year":"2023","unstructured":"Li L, Zhao Z, Li X (2023) Meta-analysis of decitabine pretreatment-based allogeneic hematopoietic stem cell transplantation affecting transplantation-related complications and prognosis in patients with malignant hematological disease. Cell Mol Biol 69(14):69\u201375. https:\/\/doi.org\/10.14715\/cmb\/2023.69.14.11","journal-title":"Cell Mol Biol"},{"key":"7154_CR18","doi-asserted-by":"publisher","unstructured":"Zhao XL, Jiang EL, Zhai WH et al (2019) Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia Chinese 14. 40(6):467\u2013471. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2019.06.004","DOI":"10.3760\/cma.j.issn.0253-2727.2019.06.004"},{"key":"7154_CR19","doi-asserted-by":"publisher","unstructured":"Yao W, Chu X, Fang X et al(2020)Decitabine prior to salvaged cord blood transplantation for acute myeloid leukaemia\/myelodysplastic syndrome not in remission. J Clin Pharm Ther 45(6):1372\u20131381. https:\/\/doi.org\/10.1111\/jcpt.13231","DOI":"10.1111\/jcpt.13231"},{"issue":"11","key":"7154_CR20","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/bmt.2017.175","volume":"52","author":"M Ogata","year":"2017","unstructured":"Ogata M, Oshima K, Ikebe T et al (2017) Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl 52(11):1563\u20131570. https:\/\/doi.org\/10.1038\/bmt.2017.175","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"7154_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/bmt.2012.180","volume":"48","author":"ME Scheurer","year":"2012","unstructured":"Scheurer ME, Pritchett JC, Amirian ES et al (2012) )HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transpl 48(4):574\u2013580. https:\/\/doi.org\/10.1038\/bmt.2012.180","journal-title":"Bone Marrow Transpl"},{"issue":"19","key":"7154_CR22","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1182\/blood-2010-10-316083","volume":"117","author":"DM Zerr","year":"2011","unstructured":"Zerr DM, Fann JR, Breiger D et al (2011) )HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 117(19):5243\u20135249. https:\/\/doi.org\/10.1182\/blood-2010-10-316083","journal-title":"Blood"},{"issue":"11","key":"7154_CR23","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.bbmt.2010.05.009","volume":"16","author":"Y Mori","year":"2010","unstructured":"Mori Y, Miyamoto T, Nagafuji K et al (2010) High incidence of human herpes virus 6-associated encephalitis\/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transpl 16(11):1596\u20131602. https:\/\/doi.org\/10.1016\/j.bbmt.2010.05.009","journal-title":"Biol Blood Marrow Transpl"},{"key":"7154_CR24","doi-asserted-by":"crossref","unstructured":"Polprasert C, Schulze I, Sekeres MA et al (2015) Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. Cancer Cell 27(5):658\u2009\u2013\u200970. https:\/\/doi.10.1016\/j.ccell.2015.03.017","DOI":"10.1016\/j.ccell.2015.03.017"},{"key":"7154_CR25","doi-asserted-by":"crossref","unstructured":"Chlon TM, Stepanchick E, Hershberger CE et al (2021) Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia. Cell Stem Cell 28(11):1966\u20131981. https:\/\/doi.10.1016\/j.stem.2021.08.004","DOI":"10.1016\/j.stem.2021.08.004"},{"key":"7154_CR26","doi-asserted-by":"crossref","unstructured":"Lee KG, Kim SS, Kui L et al (2015) Bruton\u2019s tyrosine kinase phosphorylates DDX41 and activates its binding of dsDNA and STING to initiate type 1 interferon response. Cell Rep 10(7):1055-65. https:\/\/doi.10.1016\/j.celrep.2015.01.039","DOI":"10.1016\/j.celrep.2015.01.039"},{"key":"7154_CR27","doi-asserted-by":"crossref","unstructured":"Zhang Z, Yuan B, Bao M et al (2091) (2012)The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 12(10):959\u2009\u2013\u200965. https:\/\/doi.10.1038\/ni","DOI":"10.1038\/ni.2091"},{"issue":"11","key":"7154_CR28","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1097\/TXD.0000000000001226","volume":"7","author":"M Spadea","year":"2021","unstructured":"Spadea M, Saglio F, Tripodi SI et al (2021) )Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute Leukemias. Transpl Direct 7(11):e774. https:\/\/doi.org\/10.1097\/TXD.0000000000001226","journal-title":"Transpl Direct"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07154-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07154-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07154-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:50:46Z","timestamp":1791669046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07154-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["7154"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07154-2","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from the patients for the publication of any potentially identifiable data included in this article.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Affiliated Hospital of Jining Medical University (No. 2025-09-007). The parents of the patient have provided written informed consent for both treatment and publication.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"418"}}